ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 67.19

Change

+0.29 (+0.43)%

Market Cap

CAD 0.23B

Volume

750.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.54 (+1.15%)

CAD 3.43B
ZWU:CA BMO Covered Call Utilities ETF

+0.04 (+0.33%)

CAD 1.81B
XIT:CA iShares S&P/TSX Capped Informa..

+0.43 (+0.62%)

CAD 0.78B
HTA:CA Harvest Tech Achievers Growth ..

+0.17 (+0.89%)

CAD 0.68B
TXF:CA First Asset Tech Giants Covere..

+0.20 (+0.94%)

CAD 0.67B
XHC:CA iShares Global Healthcare (CAD..

+0.11 (+0.16%)

CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.15 (+0.68%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.09 (+0.32%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

+0.33 (+0.57%)

CAD 0.31B
COW:CA iShares Global Agriculture Com..

-0.33 (-0.51%)

CAD 0.27B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.41% 20% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.41% 11% F 15% F
Trailing 12 Months  
Capital Gain -2.61% 17% F 17% F
Dividend Return 0.73% 25% F 6% D-
Total Return -1.88% 11% F 15% F
Trailing 5 Years  
Capital Gain 10.71% 37% F 49% F
Dividend Return 2.27% 16% F 4% F
Total Return 12.98% 17% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain 4.09% 34% F 48% F
Dividend Return 4.49% 23% F 44% F
Total Return 0.40% 27% F 29% F
Risk Return Profile  
Volatility (Standard Deviation) 16.09% 63% D 53% F
Risk Adjusted Return 27.90% 20% F 43% F
Market Capitalization 0.23B 65% D 48% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.